Invention Grant
- Patent Title: Tri-salt form of metformin
- Patent Title (中): 三盐形式的二甲双胍
-
Application No.: US13841970Application Date: 2013-03-15
-
Publication No.: US08765811B2Publication Date: 2014-07-01
- Inventor: Banavara L. Mylari , Frank C. Sciavolino
- Applicant: Thetis Pharmaceuticals LLC
- Applicant Address: US CT Southport
- Assignee: Thetis Pharmaceuticals LLC
- Current Assignee: Thetis Pharmaceuticals LLC
- Current Assignee Address: US CT Southport
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Muriel Liberty
- Main IPC: C07C279/02
- IPC: C07C279/02

Abstract:
Provided herein are tri-salt compounds comprising a compound having two acidic functional groups and one basic functional groups (e.g., aspartate or glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentaenoate or docosahexaenoate. The salts can be used in the treatment of diabetes, diabetes with concomitant dyslipidemia (e.g., high triglycerides) and diabetes exacerbated cardiovascular complications, such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy, and stroke. The compounds of this invention are also useful in treating obesity.
Public/Granted literature
- US20140018419A1 TRI-SALT FORM OF METFORMIN Public/Granted day:2014-01-16
Information query